MDL 3094 — Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
Pending on the 2026-08-03 JPML roster.
3,928
actions pending (2026-08-03)
3,962
total actions ever centralized
| Full caption | IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation |
|---|
| Transferee judge | Marston, Karen S. |
|---|
| District | PAE |
|---|
| Master docket | 2:24-md-3094 |
|---|
| First action filed | 2023-12-01 |
|---|
| Centralized (transferred) | 2024-02-02 |
|---|
| On our roster archive | 2024-03-01 → 2026-08-03 (27 monthly reports) |
|---|
Pending actions over time
Civil actions pending in this MDL, from JPML's monthly Actions-Pending reports.
Roster timeline
Each cell is one monthly JPML report (2014-02-19 → 2026-08-03);
filled cells are months this MDL was on the pending roster.
20142026
Related Drugs & Medical Devices
- MDL 2738 — Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation — 68,914 pending
- MDL 2846 — Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation — 23,321 pending
- MDL 2789 — Proton-Pump Inhibitor Products Liability Litigation (No. II) — 11,321 pending
- MDL 2666 — Bair Hugger Forced Air Warming Devices Products Liability Litigation — 8,407 pending
- MDL 2570 — Cook Medical, Inc., IVC Filters Marketing, Sales Practices and Products Liability Litigation — 6,537 pending
- MDL 3140 — Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability Litigation — 6,294 pending
All drugs & medical devices MDLs →
Sources
Roster presence is our derivation from JPML's monthly PDFs; confirm current
status with the court before relying on it.